116 related articles for article (PubMed ID: 9066051)
1. Duration of protective immunity in experimental canine babesiosis after homologous and heterologous challenge.
Vercammen F; De Deken R; Maes L
Vet Parasitol; 1997 Jan; 68(1-2):51-5. PubMed ID: 9066051
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using the IFAT.
Vercammen F; De Deken R; Maes L
Parasite; 1995 Dec; 2(4):407-10. PubMed ID: 8745740
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate.
Brandão LP; Hagiwara MK; Myiashiro SI
Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
[TBL] [Abstract][Full Text] [Related]
6. Antibody response and duration of latent infection in sheep following experimental infection with Babesia ovis.
Habela M; Reina D; Nieto C; Navarrete I
Vet Parasitol; 1990 Feb; 35(1-2):1-10. PubMed ID: 2188415
[TBL] [Abstract][Full Text] [Related]
7. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Babesia bigemina, B. bovis, B. divergens and B. major by Western blotting--first report of B. bovis in Austrian cattle.
Edelhofer R; Müller A; Schuh M; Obritzhauser W; Kanout A
Parasitol Res; 2004 Mar; 92(5):433-5. PubMed ID: 14745547
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of canine babesiosis in Hungary suggesting breed predisposition.
Hornok S; Edelhofer R; Farkas R
Parasitol Res; 2006 Nov; 99(6):638-42. PubMed ID: 16715235
[TBL] [Abstract][Full Text] [Related]
10. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
[TBL] [Abstract][Full Text] [Related]
11. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
[TBL] [Abstract][Full Text] [Related]
12. Canine babesiosis caused by Babesia canis vogeli in rural areas of the State of Minas Gerais, Brazil and factors associated with its seroprevalence.
Costa-Júnior LM; Ribeiro MF; Rembeck K; Rabelo EM; Zahler-Rinder M; Hirzmann J; Pfister K; Passos LM
Res Vet Sci; 2009 Apr; 86(2):257-60. PubMed ID: 18723199
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture.
Schetters TP; Kleuskens J; Scholtes N; Bos HJ
Parasite Immunol; 1992 May; 14(3):295-305. PubMed ID: 1625906
[TBL] [Abstract][Full Text] [Related]
14. Comparison between a soluble antigen-based ELISA and IFAT in detecting antibodies against Babesia canis in dogs.
Furuta PI; Oliveira TM; Theixeira MC; Rocha AG; Machado RZ; Tinucci-Costa MG
Rev Bras Parasitol Vet; 2009; 18(3):41-5. PubMed ID: 19772774
[TBL] [Abstract][Full Text] [Related]
15. Characterization and comparison of merozoite antigens of different Babesia canis isolates by serological and immunological investigations.
Hauschild S; Shayan P; Schein E
Parasitol Res; 1995; 81(8):638-42. PubMed ID: 8570577
[TBL] [Abstract][Full Text] [Related]
16. Primary Babesia rodhaini infection followed by recovery confers protective immunity against B. rodhaini reinfection and Babesia microti challenge infection in mice.
Wang G; Efstratiou A; Adjou Moumouni PF; Liu M; Jirapattharasate C; Guo H; Gao Y; Cao S; Zhou M; Suzuki H; Igarashi I; Xuan X
Exp Parasitol; 2016 Oct; 169():6-12. PubMed ID: 27423972
[TBL] [Abstract][Full Text] [Related]
17. Canine babesiosis: indirect fluorescent antibody test for a North American isolate of Babesia gibsoni.
Anderson JF; Magnarelli LA; Sulzer AJ
Am J Vet Res; 1980 Dec; 41(12):2102-5. PubMed ID: 7011131
[TBL] [Abstract][Full Text] [Related]
18. [Asymptomatic carriers of Babesia canis in an enzootic area].
Wlosniewski A; Leriche MA; Chavigny C; Ulmer P; Donnay V; Boulouis HJ; Mahl P; Druilhe P
Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):75-86. PubMed ID: 9132337
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Babesia canis infection in clinically healthy dogs from western Romania.
Imre M; Farkas R; Ilie M; Imre K; Hotea I; Morariu S; Morar D; Dărăbuş G
J Parasitol; 2013 Feb; 99(1):161-3. PubMed ID: 22681255
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of serodiagnostic assays with recombinant BgSA1 of Babesia gibsoni.
Mandal M; Banerjee PS; Kumar S; Garg R; Ram H; Kundu K; Raina OK
Vet Parasitol; 2014 Oct; 205(3-4):483-9. PubMed ID: 25241636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
